David Deitch, PhD, is the Founder of the Center for Criminality and Addiction Research, Training
and Application (CCARTA) at the currently Emeritus Professor of Clinical Psychiatry at the
University of California, San Diego. Dr. Deitch has over 45 years of experience in the development of drug abuse treatment systems for adolescents and adults, nationally and internationally. In the non-profit public health sector, he was Co-Founder of Daytop Village, Inc., and also served as Senior Vice President and Chief Clinical Officer for Phoenix House’s Foundation. In the academic sector, he has had appointments at Temple University, the University of Chicago, University of California at San Francisco, as well as serving as Chief of Substance Abuse Services for the University of California, San Francisco. In the government sector, he has served as Coordinator of Curriculum and Faculty for the United Nations East Central European Drug Abuse Treatment Training Project; has consulted to a variety of Department of Corrections and Ministries of Justice and Health, in Latin America, SE Asia and Europe. Dr. Deitch served during the Johnson Administration as consultant to the Presidential Commission for the Study of Crime and Juvenile Delinquency, and the National Commission on Marijuana and Drug Abuse. During the Carter Administration, he chaired the White House Task Force on Prevention. He chaired the Curriculum Development Committee of the National Addiction Technology Transfer Centers, Technical Assistance Publication Series 21 — The Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice, used today as a guideline for corrections and community based substance abuse treatment organizations. He has further served as Regional Director of the Executive Committee of the Association for Medical Education and Research in Substance Abuse — Mentor Project (2000). He has numerous publications (and videos) in the field.
Igor Koutsenok, MD, MS is а Professor of Psychiatry at the University of California San Diego, Director of the Center for Addiction Research, Training and Application, Director of the UCSD-Second Chance Reentry Academy, and a co-director of the SAMHSA South East Asia Addiction Technology Transfer Center. He graduated as a medical doctor in 1983 at the National Medical University in Kiev, (Ukraine). In 1986, he completed his psychiatry residency training and received degree as psychiatrist from the Medical University in Sofia (Bulgaria). In 1992-1996 he completed fellowship in addiction psychiatry at the University of London, Department of Addictive Behavior and Psychological Medicine at St. Georges Hospital Medical School. In 1996, he was recruited by the University of California San Diego, School of Medicine, Department of Psychiatry and since then he serves as faculty member of the Department. In 2013-2016 he served as Director of Prevention, Treatment, and Rehabilitation at the United Nations Office on Drugs and Crime, United Nations Office in Vienna. Over the last 20 years Dr. Koutsenok led the design and implementation of multiple training and technical assistance programs for addiction treatment, mental health practitioners, primary health care and social work practitioners, criminal justice professionals in the United States and around the world. Dr. Koutsenok served as a trainer for the National Drug Court Institute in the USA. Dr. Koutsenok is also a member of the International Motivational Interviewing Network of Trainers (MINT). For many years, Dr. Koutsenok teaches general and addiction psychiatry to medical students, psychiatry residents, psychology trainees, social workers, criminal justice professionals, and policy makers around the world. He is a recipient of numerous national and international awards. He has authored and co-authored over 50 scientific publications and 5 book chapters. Dr. Koutsenok has been invited as a presenter and trainer to hundreds of conferences and workshops in the USA and more than 40 countries around the world. He is a proud father of three.
2018 UCSD SCI Distinguished Faculty
Robert M. Anthenelli, MD is Professor and Executive Vice Chair in the Department of Psychiatry at the University of California, San Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He previously served as the Associate Chief of Staff for Mental Health at the VA San Diego Healthcare System and Vice Chair for Veterans Affairs. He was formerly a Professor of Psychiatry, Psychology and Neuroscience at the University of Cincinnati, College of Medicine where he founded and directed the
Center for Treatment, Research & Education in Addictive Disorders and the Addiction Sciences Division.
Dr. Anthenelli earned his baccalaureate degree from The Johns Hopkins University in Baltimore, Maryland, USA and his MD degree from The Johns Hopkins University School of Medicine. After graduating medical school, he completed his internship in internal medicine at Mercy Hospital in Baltimore. Dr. Anthenelli did residency training in psychiatry at the University of California, San Diego, School of Medicine. Additional post-doctoral training included a 2-year fellowship in addiction psychiatry research that was funded by the Department of Veterans Affairs.
The overarching theme of Dr. Anthenelli’s research is to develop improved treatments for tobacco and alcohol dependence by better understanding the neurobiology of these disorders. His lab group is also interested in the genetic influences on these disorders, the relationship between stress and relapse to addiction, and sex differences in stress and treatment responsivity. Funding for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the Department of Veterans Affairs, and various industry sponsors.
Kara S. Bagot, MD is a Child and Adolescent Psychiatrist and Assistant Professor in the University of California, San Diego Department of Psychiatry. She received her psychiatric and clinical research training at Yale University Child Study Center. Dr. Bagot is a clinician and researcher with expertise in treatment interventions for adolescent Substance Use Disorders, and has authored and presented several manuscripts in this field. Her research focuses on understanding psychosocial, biological and psychiatric factors that contribute to the developmental trajectory of substance use in adolescents, and development of efficacious treatment interventions that can be implemented in naturalistic settings.
Jim Carter, PhD currently works as a senior consultant at Learning Designs, Inc. He enjoys providing consultation and staff training focused on Motivational Interviewing (MI) and Cognitive Behavioral Therapies (CBT). Dr. Carter is a member of Motivational Interviewing Network of Trainers (MINT), and a diplomate for the Academy of Cognitive Therapy. Since 1999, he has held a license as a clinical psychologist, and has treated patients in hospital, correctional, and private practice settings. Dr. Carter possesses specialized training in the areas of addiction, behavioral pharmacology, MI, CBT, and staff training and development. He served as Associate Director of Addiction Treatment Services at Johns Hopkins Bayview Medical Center, and as Instructor in the Department of Psychiatry at Johns Hopkins School of Medicine. During the course of his career, Dr. Carter has authored research articles in scientific journals, served as an expert reviewer, and as a co-principal investigator of publicly funded clinical trial research studies. He is a husband, father, and avid saltwater angler.
Thom Browne, Jr., MA Rubicon Global Enterprises: President and CEO (Aug. 2015 – present) Colombo Plan Secretariat: Chief Executive Officer (Jan. 2016 – present) Provides global technical assistance on drug prevention, treatment, recovery, and criminal justice issues. Chairs international working groups to develop certification for addictions counselors, licensing for treatment centers, and networks of treatment/prevention professionals. Serves as expert advisor to selected international organizations on counter- narcotics issues. Develops specialized programs addressing unique international challenges such as identification of toxic adulterants added to drugs of abuse and related public health responses. Developed the U.S. government's program and approach to international drug demand reduction for over 25 years as the U.S. Department of State's Division Director for Criminal Justice Programs.
David Grelotti, MD is an Assistant Professor of Psychiatry at the University of California San Diego and an Investigator at the University of California Center for Medicinal Cannabis Research. He graduated from medical school at The Johns Hopkins University School of Medicine and completed residency training in the Harvard Medical School Combined Pediatrics, Adult Psychiatry, and Child Psychiatry Residency Training Program at Massachusetts General Hospital and McLean Hospital. After residency training, he worked extensively in Haiti and Africa to close the treatment gap for mental, neurological, and substance use disorders. At UC San Diego, he is the Director of HIV Psychiatry and conducts research on HIV syndemics, global mental health, and medicinal cannabis. Active research efforts include: novel systems for the delivery of mental health treatment for people living with HIV in Haiti and the US; the relationship between HIV and cannabis, heroin, and recreational antiretroviral use in South Africa; and cannabis-related driving impairment and a randomized, placebo-controlled clinical trial of cannabis for low back pain at the Center for Medicinal Cannabis Research. His research is funded by the National Institutes of Health and the State of California.
Kimberly Johnson, PhD
Laurie Krom, MS is a Program Director in the Collaborative for Excellence in Behavioral Health Research and Practice at the University of Missouri-Kansas City’s School of Nursing and Health Studies. Ms. Krom is a leader in grant development and implementation, having received several multi-million dollar federal awards. She is the PI/Co-Director of the SAMHSA- funded Addiction Technology Transfer Center Network Coordinating Office and the PI/Co-Director of the CDC-funded National Capacity Building Assistance for High Impact HIV Prevention Resource Center. Ms. Krom’s expertise is in building and strengthening interorganizational networks to deepen the impact of public health collaborations. She is a lifelong learner in transformative education, facilitative leadership and technology transfer, and a recognized leader in the substance use disorder treatment field.
Carla Marienfeld, MD, is an addiction psychiatrist and an Associate Clinical Professor of Psychiatry at University of California San Diego. Clinically, she focuses on the treatment of patients with substance use disorders and co-morbid psychiatric conditions. She previously worked at a large outpatient addiction treatment program serving over 5000 patients. Her academic interests focus on implementation research and large-data health outcomes for patients with substance use disorders, as well as training and education in Motivational Interviewing. She attended Baylor College of Medicine in Houston, TX, where she completed the International Health Track, served nationally on the Board of Trustees of the American Medical Student Association (AMSA), and earned Alpha Omega Alpha (AOA) Medical Honors Society and Honors distinction. During psychiatry residency at Yale, she served as chief resident, a National Institute of Drug Abuse R25 Research Fellow, and as the resident representative to the Accreditation Council for Graduate Medical Education (ACGME), while also earning several awards and fellowships. She completed a fellowship in Addiction Psychiatry at Yale. During residency and her early faculty years, she founded and led the Yale Global Mental Health Program. She served as the site training director for the Yale New Haven Hospital Addiction Psychiatry Fellowship and supervised and taught medical students for psychiatry, residents for global mental health, and fellows for addiction psychiatry. She has come to UCSD to help in the development and implementation of a new Addiction Recovery and Treatment Program. This will be a full service ambulatory program for the treatment of substance use and other co-occurring mental disorders (i.e. anxiety, depression, PTSD), offering a continuum of services including a comprehensive evaluation, individual, family and group therapy, medication management, and linkage to community resources. She is the Director for Addiction Services and the Medical Director of the Addiction Recovery and Treatment Program at UCSD.
Michal Miovský, PhD, MA is a professor of Clinical psychology on Charles University in Prague (Czech Republic). He graduated from the Philosophical Faculty of Masaryk University in Brno in 1998. In 2002, he received a Ph.D. degree in Clinical Psychology at Palacky University in Olomouc. In the same year, he was employed as a researcher at the Institute of Psychology of the Academy of Science of the Czech Republic. He has started his professional carrier as a volunteer and therapist in Drop-in centre and in school prevention. Later he established therapeutic centre for drug users and leaded group of treatment facilities (Therapeutic community, Aftercare, Day centre and Substitution centre) in NGO “Podane ruce” in Brno.
He is vice-dean for non-medical health study programs on the 1st Medical Faculty and Head Department of Addictology of the 1st Medical Faculty, Charles University, Prague and General teaching Hospital in Prague. He leaded creating and establishing Bachelor (BC), master (MA) and postgraduate (PHD) addiction study program on the Charles University in Prague.
He is president of ISAJE (International Society of Addiction Journal Editors) and Deputy Editor-in-Chief in Journal of Adiktologie (Addictology) and he established the Journal with his colleagues in 2001. He is also a member of the editorial boards of Journal of Groups in Addiction and Recovery, Czech and Slovak Psychiatry and other Journals. He is specialized in qualitative methods and research in the field of addictions, prevention and clinical research (e.g. ADHD etc.). He is president of International Consortium of Universities on Drug Demand Reduction (ICUDDR).
Roger H. Peters, PhD is a Professor in the Department of Mental Health Law and Policy at the Louis de la Parte Florida Mental Health Institute (FMHI), University of South Florida (USF), where he has served as a faculty member since 1986, and as Department Chair from 2004-2011. Dr. Peters holds a joint appointment in USF’s College of Public Health. Dr. Peters received his Ph.D. in clinical psychology from the Florida State University, following completion of a pre-doctoral internship at the University of North Carolina, School of Medicine, and is a licensed Psychologist in Florida. Dr. Peters has served as Principal Investigator and Director for several grant projects, including a NIDA P30 Research Core Center on Co-Occurring Disorders, Justice, and Multidisciplinary Research. He currently serves on the Florida Supreme Court’s Task Force for Mental Health and Substance Abuse Issues in the Courts, and has been a faculty member of the National Judicial College since 2014. Dr. Peters also serves on the editorial boards for the Psychiatric Rehabilitation Journal, the Journal of Dual Diagnosis, Addictology, and Journal for Advancing Justice. Dr. Peters served as Chair and Co-Editor of the SAMHSA/CSAT Treatment Improvement Protocol (TIP) #44 on “Substance Abuse Treatment for Adults in the Criminal Justice System”. He is also the lead author of the monograph “Screening and Assessment of Co-Occurring Disorders in the Justice System” (3rd edition) which was published by SAMHSA in 2016. In 2015 Dr. Peters served as a Fulbright Scholar at the University of Cape Coast in Ghana, and received a second Fulbright Specialist grant in 2017 with the Universidad Catolica in Asuncion, Paraguay. Dr. Peters serves as Director of the Universal Treatment Curriculum (UTC) Coordinating Center for North American Universities, located at USF, and as Vice President of the International Consortium of Universities for Drug Demand Reduction (ICUDDR).
Mark B. Reed, PhD is the Interim Associate Dean in the College of Health and Human Services and a Professor in the San Diego State University (SDSU) School of Social Work. He is a founding faculty member in the SDSU/UCSD Interdisciplinary Research on Substance Use doctoral program. Dr. Reed’s research focuses on alcohol and other drug use etiology and prevention with an emphasis on social ecological models of substance use behaviors as well as Screening, Brief Intervention, Referral to Treatment (SBIRT) approaches to alcohol misuse. He is well published in top substance use/public health journals and has served as Principal Investigator, Co-Principal Investigator, or Co-Investigator on grants and contracts funded by the National Institutes of Health (NIAAA), the Congressionally Directed Medical Research Program, California Tobacco-Related Disease Research Program, the Flight Attendants Medical Research Institute, and The Ohio State University. He is the incoming President of the American Academy of Health Behavior and is an ad-hoc reviewer for over 20 substance use/public health journals and serves as the Co-Editor-in-Chief for the International Journal of Alcohol and Drug Research. In his spare time Dr. Reed can be found mountain biking or road cycling in San Diego county and beyond.
Elizabeth Sáenz, MD, Pediatrician, MSc PHDC, London School of Hygiene and Tropical Medicine, MSc MCH, ICH, University College London, UK, is a physician and public health specialist, with more than twenty years experience in the field of human health and development. Her in-depth understanding of this complex field is underpinned by a broad base of experience with international organizations such as the Pan-American Health Organization, the United Nations Population Fund and, most recently, the United Nations Office on Drugs and Crime (UNODC). Sáenz joined the UNODC Prevention, Treatment and Rehabilitation Section/Drug Prevention and Health Branch in 2007 as an Expert, and since 2010 holds the position as Project Coordinator.
For the past 12 years at UNODC she has been working in the field of drug demand reduction, leading a team in the implementation of global projects on drug dependence treatment and care in more than 40 countries. This project portfolio includes Treatnet II and the UNODC-WHO joint programme on Drug Dependence Treatment and Care partnership programme, which are widely regarded as excellent examples of interagency collaboration and aim at enhancing the institutional knowledge and understanding of Governments, civil society and UN agencies of evidence-based drug treatment. Sáenz has also been involved in the development of key technical tools publications produced by UNODC over the past ten years.
Elizabeth Sáenz is married and mother of two.
Marc A. Schuckit, MD, is Professor of Psychiatry and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA San Diego Healthcare System. Dr. Schuckit received his BS from the University of Wisconsin, an MD from Washington University, interned at Cedars Sinai Medical Center, and was a resident in psychiatry at Washington University and UCSD. He was a special advisor to the Commanding Officer of the Naval Health Research Center, and the first Director of the Alcohol and Drug Institute, University of Washington (1975-1978). He returned to San Diego as Professor and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA San Diego Healthcare System. Dr. Schuckit’s major focus is alcohol and drugs. He was Chair of the DSM-IV substance disorders workgroup and has published papers about the optimal diagnostic criteria for substance use disorders. Regarding the genetics of alcoholism, he has carried out adoption studies, identified a genetic characteristic that impacts on elevated alcoholism risk (the low level of response to alcohol), and is now searching for related genes. He is currently completing a 20-year follow-up (97% success rate) of sons of alcoholics where he is trying to identify environmental events that might relate to whether biological predisposition toward alcohol dependence is expressed. An additional research area is co-morbidity between substance use disorders and major psychiatric conditions.
Dr. Schuckit directs the Alcohol and Drug Treatment Program at the VA San Diego Healthcare System, supervising residents, medical students and staff. He is also a major contact person regarding alcohol and drug problems in faculty and staff at UCSD and the San Diego VA. Additional clinical interests include the treatment of depressive disorders, anxiety conditions, and geriatric psychiatric populations.
María Luisa Zúñiga, PhD is Professor in the School of Social Work at San Diego State University (SDSU) and Associate Adjunct Professor in the Division of Global Public Health and Department of Pediatrics, UC San Diego (UCSD). Serves as the Campus Director of the SDSU-UCSD Joint Doctoral Program in Interdisciplinary Research on Substance Use (JDP) (http://socialwork.sdsu.edu/irsu/). The JDP is a new doctoral program designed to train the next generation of substance use researchers to lead high caliber, high impact and meaningful substance use research to reduce the impact of problems related to substance use, misuse, addiction and co-occurring conditions.
She is an epidemiologist with over 18 years of experience conducting transnational and Community-Based Participatory Research. Dr. Zúñiga’s research goal is to improve health among persons of Latin American origin who are at risk for or adversely impacted by alcohol and drug use, poor mental health, and TB/HIV. She has worked extensively with immigrant communities and communities in the U.S.-Mexico border region as well as Mexican transnational and domestic migrants and their families in Mexico. Her ongoing research is designed to understand and improve engagement and retention of patients in health care, patient-clinician communication, and binational care continuity in the context of the U.S.-Mexico border region. Specific populations with whom she works include persons living with HIV and/or Tuberculosis, and persons impacted by substance abuse. Recent efforts include development of interdisciplinary collaborations in HIV/TB/Substance use research with colleagues in the U.S. and Brazil.
Summer clinical institute in addiction studies